乘客基因协同增强在癌症中创造了附带的治疗脆弱性.
Yi Bei1, Luca Bramé1,2, Marieluise Kirchner3
1Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Cancer discovery
|January 10, 2024
概括
癌症中乘客基因的共同增强可以创造新的治疗脆弱性. 死亡盒化酶1 (DDX1) 基因联合增强增加了对mTOR途径的依赖,为癌症治疗提供了一个新的标.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 癌症中的DNA放大经常含有瘤基因.
- 往往被忽视的乘客共同放大也可能影响癌症的进展和治疗.
- 了解这些乘客事件对于全面的癌症治疗策略至关重要.
研究的目的:
- 调查乘客基因共同增强是否会造成附带的治疗脆弱性.
- 确定由乘客共同放大产生的特定依赖关系.
- 探索针对乘客基因所造成的弱点的治疗潜力.
主要方法:
- 分析了3000多个癌症基因组.
- 在700多个癌细胞系中,对CRISPR-Cas9功能丧失查进行了审问.
- 涉及DEAD-Box Helicase 1 (DDX1) 基因,相互作用蛋白质学和活细胞代谢学的原理证明研究.
主要成果:
- 乘客共同放大与不同的癌细胞依赖性概况有关.
- 乘客基因DDX1的联合增强增强了对mTOR通路的依赖.
- DDX1与三碳酸 (TCA) 循环组件相互作用,损害TCA活性并增加mTORC1活性.
- 破坏mTORC1导致显著的癌细胞死亡在体外和体内.
结论:
- 乘客基因和瘤基因的结构链接的共同增强可以导致附带的治疗脆弱性.
- 乘客共同放大是癌症依赖的重要,以前被低估的来源.
- 这个原则为扩大瘤学中目标发现提供了一个有希望的途径.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K


